A study may explain why some patients with Crohn's disease continue to experience symptoms, even in the absence of inflammation.

A new study may explain why some Crohn's disease patients still experience symptoms despite the absence of inflammation.

A study from University of Michigan researchers may provide an explanation for why some patients with Crohn's disease continue to experience symptoms, even in the absence of inflammation.

A study from University of Michigan researchers may provide an explanation for why some patients with Crohn's disease continue to experience symptoms ...

Researchers have uncovered potentially diagnostic gut microbiome signatures and metabolic pathways associated specifically ...

Teva Pharmaceuticals and Sanofi announced positive results in a Phase 2b trial of their drug for ulcerative colitis and Crohn ...

As part of the ongoing Human Cell Atlas project, researchers mapped 1.6 million cells in the gastrointestinal tract. Here’s ...

Inflammatory bowel disease (IBD), consisting primarily of ulcerative colitis and Crohn's disease, is a group of debilitating ...

The dramatic rise is another peak in Teva's recovery over the past year and rewards investors after a long period of ...

A new gut cell atlas, comprising data from 1.6 million cells, offers unprecedented insights into gastrointestinal health and disease. A research team led by the Wellcome Sanger Institute has created t ...

New research from the Human Cell Atlas offers insights into cell development, disease mechanisms, and genetic influences, ...

LIVE: Investors in India are likely to remain cautious amid mixed global cues as investors here and elsewhere await key ...